THIRD FUNDING ROUND TO BE ANNOUNCED NOVEMBER 2020
The BSAC COVID-19 Funding programme has to date supported 2 grant funding calls. Both were open callS for funding to support grant applications in response to the current coronavirus (COVID-19) public health emergency, with the 2nd call having a specific focus on the impact COVID-19 on antimicrobial resistance and antimicrobial stewardship agenda.
FIRST GRANT FUNDING CALL – MAY 2020
Funded from BSAC reserves supported by unrestricted educational grants from Pfizer and Shionogi
The first call attracted 389 expressions of interest. Following triage 54 applicants from 15 countries were invited to submit full grant applications for grants to a maximum of £25,000.
The applications were externally reviewed by a review pool comprising 22 internationally renowned experts. 11 grants were awarded.
SECOND GRANTS CALL – AWARDED OCTOBER 2020
Funded by an unrestricted educational grant from Pfizer
This was an open and worldwide open call for research grant applications to support grant applications in response to the current coronavirus (COVID-19) public health emergency. The call supported all aspects of COVID-19 research from all countries but with specific interest in expressions of interest from (a) researchers in low-to-middle-income countries, or applications that address aspects of COVID-19 in LMIC communities and (b) that address the impact of COVID-19 on the antimicrobial resistance and antimicrobial stewardship agenda.
This call was issued in June 2020 attracted 105 expressions of interest (52% from LMICs). Following triage 29 applicants from 12 countries were invited to submit full grant applications. To reflect the global nature of this grants call, funding was offered in US Dollars. Funding aimed to support grants within each of the following funding brackets:
25 full applications were received, and peer reviewed by a pool of 27 international reviewers. Applicants from LMICs were offered independent support (by individuals outside of the peer review pool) in developing applications if such support was required and where English was not first language. 8 grants were awarded based on scientific excellence following peer review.
Details of the grants awarded can be accessed below.
Use of funds
Funds awarded will be used solely to support research studies and researchers performing Research. No portion of the Funding may be used to purchase capital equipment such as computers, iPhones, tablets, appliances, machinery, camera equipment, sensors, etc. None of the funds are used to underwrite the contributions of BSAC in peer reviewing and managing the awards; these costs are met from the charitable income of the Society.
Intellectual Property – a note of explanation
BSAC receives a large number of enquiries in relation to IP as explained in the Terms and Conditions of grant awards. Changes to the clause are not open for negotiation but the following will help place the clause in context:
BSAC is a registered charity and has a duty to seek a return on any charitable investments it makes, including grant funding. The IP clause included in the terms and conditions makes provisions, through the sharing of IP between funder and institution, for the Society, in the event of commercialisation of IP to secure a return on grant funding investment. The percentage share of income arising from commercialisation of IP would be after deduction of all costs arising from the same and would be negotiated according to the relative contributions of both parties. Any income derived is used solely to further the charitable aims of the Society, such as the provision of grant funding.
For all enquiries please email email@example.com
History of BSAC grants awarded: BSAC grants awarded
This grants call has been funded through an unrestricted grant from Pfizer. Other companies or organisations wishing to support this funding programme should contact Tracey Guise by email.